How to Reconstitute Selank

Selank is the common name for a synthetic heptapeptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro, a stabilized analog of the endogenous immunomodulatory tetrapeptide tuftsin (Thr-Lys-Pro-Arg). It is supplied as a lyophilized white powder for laboratory research and is handled as a reconstituted solution in most in vitro and animal work. The evidence base available here does not supply a CAS number, a molecular formula, or a molecular weight for the compound, so none is stated on this page.

The research literature indexed in the evidence set below centres on neurocognitive and neurophysiological endpoints — cortical oscillatory activity, attention, and reading-related processing — rather than on the peptide's own receptor pharmacology, and no study in that set administers Selank itself.

Research Studies

Selank and the absence of direct reconstitution data in the indexed literature

None of the studies in the evidence block investigate Selank, its stability in solution, its reconstitution vehicle, or its handling characteristics. The indexed records describe interventions in other modalities entirely: balance exercise, transcranial electrical stimulation, imagery rescripting, personal sound amplification, altitude exposure, neurofeedback, transcranial magnetic stimulation, and telephone-delivered psychotherapy. A reader looking for a published reconstitution protocol for this specific peptide will not find one in this set.

What the set does provide is a picture of the endpoint families against which peptide research of this class is typically assessed — EEG-derived oscillatory measures, behavioural accuracy and reaction time, and self-report instruments. Those are the measures a laboratory would need to define before any reconstituted preparation is used.

Selank and EEG oscillatory measures in cognitive task designs

One registered study examined the effects of balance exercises performed in virtual and real environments on visual-spatial attention and mental rotation in healthy young adults, using EEG brain oscillations as the readout [1]. The design is relevant to peptide work only as a methodological template: it establishes that oscillatory EEG is treated as a primary outcome in this research area, and that healthy young adult cohorts are used for cognitive-mechanism questions.

For a laboratory characterising a reconstituted peptide, the practical implication is that EEG oscillation parameters — band power and task-related modulation — are the kind of dependent variable that would need pre-specified acquisition and analysis parameters before any compound is introduced.

Selank and reading-related cortical targets in developmental dyslexia

A separate registered trial addressed the absence of evidence-based treatment in developmental dyslexia by testing transcranial random noise stimulation and transcranial direct current stimulation over bilateral temporo-parietal cortex, with reading skill as the outcome and sham stimulation as the control [2]. The investigators hypothesised that active stimulation over those regions would boost reading skills in children and adolescents with dyslexia, and that sham would not.

The temporo-parietal cortex is the anatomical target named in that record. No evidence in this set links Selank to that region or to reading outcomes, and the finding is reported here as a fact about a stimulation study, not as a claim about the peptide.

Selank and hemispheric imbalance models in dyslexia

A neurofeedback trial described a training protocol designed to induce a functional hemispheric imbalance of the temporo-parietal regions in individuals with dyslexia, comparing left theta/beta training combined with right beta/theta training against sham neurofeedback [6]. The study is a randomised clinical trial comparing two experimental conditions.

This record is useful for one reason: it shows that hemispheric asymmetry of temporo-parietal function is treated as a manipulable variable in this literature. It says nothing about Selank.

Selank and neural reactivity to autobiographical criticism memories

A randomised controlled trial investigated the neural and psychophysiological mechanisms of imagery rescripting in individuals with high fear of failure. Participants (N=81, aged 21–34) were randomised to imagery rescripting or an active control condition, with the intervention targeting autobiographical memories of parental criticism across four sessions delivered within two weeks. Neuroimaging (fMRI), skin conductance, and self-report measures were assessed pre- and post-intervention, with follow-ups at 3 and 6 months [3].

The primary aim was to examine whether imagery rescripting reduces neural and subjective reactivity to autobiographical criticism memories. This is a psychological intervention study in a defined adult population; it does not involve peptide administration.

Selank and speech processing with personal sound amplification

An EEG study assessed the neurobiological and behavioural effects of personal sound amplification products in adults with mild to moderate hearing loss, a population in which the condition remains undertreated largely because of the cost of hearing aids [4]. The record notes that PSAP use has been shown to provide hearing benefits and improve quality of life in older adults with mild to moderate hearing loss, but that data on speech processing in the brain were insufficient.

The relevance to peptide research is again methodological: EEG is used here to measure a processing change in a clinical population, with behavioural measures collected alongside.

Selank and cognitive function under acute hypoxic exposure

A field and control study investigated the impact of rapid elevation to 3,800 metres on the cognitive function of low-altitude residents, with the stated purpose of exploring objective indicators related to impaired cognitive function [5]. The design compares a plateau field condition against a plain control.

Hypoxia is an environmental insult rather than a pharmacological one, and the record does not involve any peptide. It is included here because cognitive impairment endpoints under physiological stress are a recurring outcome family in this literature.

Selank and transcranial magnetic stimulation of object recognition

A study examined whether transcranial magnetic stimulation can interfere with the ability to identify pictures of familiar objects. The background states that when people identify a familiar object shown on a screen, communication between certain brain regions increases and can be detected by EEG, and that TMS can affect these brain waves by slightly changing brain rhythms [7].

The objective was to determine whether changing brain rhythms with TMS interferes with object recognition. The record is a stimulation study; it does not address peptides.

Selank and telephone-delivered psychotherapy for depression

A trial compared two telephone-based psychotherapy interventions for patients with mild to moderate depression. Both consisted of one personal session and weekly to bi-weekly 8–10 telephone sessions with a licensed cognitive-behavioural psychotherapist, accompanied by educational materials and regular monitoring questionnaires, over approximately three months. Patients were randomised to a condition that additionally received a motivating letter from their psychotherapist after each telephone session, or to the condition without that addition [8].

This is a behavioural intervention trial in a defined patient population. It contributes no information about Selank.

Selank and peptide signalling pathways in tissue regeneration

A review of therapeutic peptides in orthopaedics reports that peptides are emerging as adjuncts in the management of orthopaedic injuries, grounded in their ability to modulate molecular signalling networks central to cellular medicine. Acting on pathways including PI3K/Akt, mTOR, MAPK, TGF-β, and AMPK, peptides exert influence over tissue regeneration [9].

This is a general statement about the peptide class and its signalling reach, not a finding about Selank specifically, and it is not a reconstitution study. It is cited here only to indicate the pathway families that peptide research in this space engages.

Comparison of indexed study designs

What the evidence does not establish

No study in this set administers Selank, measures its concentration in solution, evaluates its stability after reconstitution, or reports a receptor-binding profile for it. Every record above concerns a different intervention in a different population. Any statement about how this peptide behaves once dissolved would therefore be unsupported by the material available here, and none is made.

Where a finding is drawn from a clinical population — children and adolescents with dyslexia [2], older adults with hearing loss [4], adults with high fear of failure [3], patients with depression [8] — the population is named because the result belongs to that population and does not generalise automatically to others.

If you are reading this for personal health reasons

This material is sold for laboratory research only, and nothing on this page is medical information. We do not provide dosing, reconstitution-for-use, or any other guidance intended for human administration. Anyone considering a compound for themselves should speak to a licensed clinician.

Sources

• [1] The Effect of Balance Exercises on Cognitive Function — https://clinicaltrials.gov/study/NCT06151093
• [2] Comparing the Efficacy of tDCS and tRNS to Improve Reading Skills in Children and Adolescents With Dyslexia — https://clinicaltrials.gov/study/NCT05832060
• [3] Neural Mechanisms and Efficacy of Imagery Rescripting for Fear of Failure — https://clinicaltrials.gov/study/NCT07196085
• [4] Effects of PSAPs on Speech Processing — https://clinicaltrials.gov/study/NCT05076045
• [5] The Study on Effects of Acute Exposure to High Altitude Hypoxia on Cognitive Function in Lowlanders — https://clinicaltrials.gov/study/NCT05411185
• [6] Neurofeedback Training for Dyslexia — https://clinicaltrials.gov/study/NCT04989088
• [7] Effects of Transcranial Magnetic Stimulation on Object Recognition — https://clinicaltrials.gov/study/NCT01747200
• [8] Trial of Telephone-based Psychotherapy for Depression With and Without Adjunctive Supportive Mail — https://clinicaltrials.gov/study/NCT01770990
• [9] Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions — https://europepmc.org/article/PMC/PMC12753158